liu.seSök publikationer i DiVA
Ändra sökning
RefereraExporteraLänk till posten
Permanent länk

Direktlänk
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Annat format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annat språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf
Short peptide analogs as alternatives to collagen in pro-regenerative corneal implants
Linköpings universitet, Institutionen för klinisk och experimentell medicin, Avdelningen för cellbiologi. Linköpings universitet, Medicinska fakulteten. LV Prasad Eye Inst, India.ORCID-id: 0000-0001-6105-1213
Antwerp Univ Hosp, Belgium; Univ Antwerp, Belgium.
Linköpings universitet, Institutionen för klinisk och experimentell medicin, Avdelningen för cellbiologi. Linköpings universitet, Medicinska fakulteten.
Cardiff Univ, Wales.
Visa övriga samt affilieringar
2018 (Engelska)Ingår i: Acta Biomaterialia, ISSN 1742-7061, E-ISSN 1878-7568, Vol. 69, s. 120-130Artikel i tidskrift (Refereegranskat) Published
Abstract [en]

Short collagen-like peptides (CLPs) are being proposed as alternatives to full-length collagen for use in tissue engineering, on their own as soft hydrogels, or conjugated to synthetic polymer for mechanical strength. However, despite intended clinical use, little is known about their safety and efficacy, mechanism of action or degree of similarity to the full-length counterparts they mimic. Here, we show the functional equivalence of a CLP conjugated to polyethylene glycol (CLP-PEG) to full-length recombinant human collagen in vitro and in promoting stable regeneration of corneal tissue and nerves in a pre- clinicalmini-pig model. We also show that these peptide analogs exerted their pro-regeneration effects through stimulating extracellular vesicle production by host cells. Our results support future use of CLP-PEG implants for corneal regeneration, suggesting the feasibility of these or similar peptide analogs in clinical application in the eye and other tissues. Statement of significance Although biomaterials comprising full-length recombinant human collagen and extracted animal collagen have been evaluated and used clinically, these macromolecules provide only a limited number of functional groups amenable to chemical modification or crosslinking and are demanding to process. Synthetic, customizable analogs that are functionally equivalent, and can be readily scaled-up are therefore very desirable for pre-clinical to clinical translation. Here, we demonstrate, using cornea regeneration as our test bed, that collagen-like-peptides conjugated to multifunctional polyethylene glycol (CLP-PEG) when grafted into mini-pigs as corneal implants were functionally equivalent to recombinant human collagen-based implants that were successfully tested in patients. We also show for the first time that these materials affected regeneration through stimulation of extracellular vesicle production by endogenous host cells that have migrated into the CLP-PEG scaffolds. (C) 2018 Acta Materialia Inc. Published by Elsevier Ltd.

Ort, förlag, år, upplaga, sidor
ELSEVIER SCI LTD , 2018. Vol. 69, s. 120-130
Nyckelord [en]
Collagen-like peptide; Recombinant human collagen; Cornea; Regeneration; Exosomes
Nationell ämneskategori
Biomaterialvetenskap
Identifikatorer
URN: urn:nbn:se:liu:diva-147108DOI: 10.1016/j.actbio.2018.01.011ISI: 000427334100009PubMedID: 29355715OAI: oai:DiVA.org:liu-147108DiVA, id: diva2:1199540
Anmärkning

Funding Agencies|Dept. of Biotechnology-Vinnova Indo-Sweden Collaborative Health Research Project grant; Integrative Regenerative Medicine Centre, Linkoping University; European Cooperation in Science and Technology (EU-COST) [BM1302-25221, BM1302-34283]; Research Foundation - Flanders [FWO - 11ZB315N]; Euronanomed2 (REGENERATE); Funds for Research in Ophthalmology (FRO); MRC program [MR/K000837/1]

Tillgänglig från: 2018-04-20 Skapad: 2018-04-20 Senast uppdaterad: 2019-03-22

Open Access i DiVA

fulltext(3774 kB)61 nedladdningar
Filinformation
Filnamn FULLTEXT01.pdfFilstorlek 3774 kBChecksumma SHA-512
3a92082b6ba70c22aaad78f96eb092548dda17db0a594d3d7258469fafe68a1d068275f490ba4b10f4a9c7a45d1baebeb599bb2801c374e1d069b20971d22177
Typ fulltextMimetyp application/pdf

Övriga länkar

Förlagets fulltextPubMedLink to correction

Sök vidare i DiVA

Av författaren/redaktören
Jangamreddy, JaganmohanMirazul Islam, Mohammad MirazulSamanta, AyanFagerholm, PerLiszka, AnetaKozak Ljunggren, MonikaBuznyk, OleksiyGriffith, May
Av organisationen
Avdelningen för cellbiologiMedicinska fakultetenAvdelningen för neuro- och inflammationsvetenskapÖgonkliniken US/LiM
I samma tidskrift
Acta Biomaterialia
Biomaterialvetenskap

Sök vidare utanför DiVA

GoogleGoogle Scholar
Totalt: 61 nedladdningar
Antalet nedladdningar är summan av nedladdningar för alla fulltexter. Det kan inkludera t.ex tidigare versioner som nu inte längre är tillgängliga.

doi
pubmed
urn-nbn

Altmetricpoäng

doi
pubmed
urn-nbn
Totalt: 233 träffar
RefereraExporteraLänk till posten
Permanent länk

Direktlänk
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Annat format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annat språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf